<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="102442">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01818960</url>
  </required_header>
  <id_info>
    <org_study_id>AC-103</org_study_id>
    <nct_id>NCT01818960</nct_id>
  </id_info>
  <brief_title>Revascularization Strategies for ST Elevation Myocardial Infarction Trial: The ASSIST-MI Trial</brief_title>
  <official_title>Revascularization Strategies for ST Elevation Myocardial Infarction Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>St. Michael's Hospital, Toronto</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>St. Michael's Hospital, Toronto</source>
  <oversight_info>
    <authority>Canada: Health Canada</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Revascularization strategies for ST elevation myocardial infarction (STEMI) study (The
      ASSIST-MI Trial) will compare the effects of two revascularization strategies [same sitting
      multivessel primary PCI (SS-PCI) and culprit vessel only primary PCI (IRA-PCI)] on
      myocardial infarct size (MIS) as determined by cardiac magnetic resonance (CMR) imaging in
      patients presenting with STEMI and multivessel disease (MVD).
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>June 2013</start_date>
  <completion_date type="Anticipated">December 2015</completion_date>
  <primary_completion_date type="Anticipated">December 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Infarct size by CMR</measure>
    <time_frame>90 days</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>MACE rate</measure>
    <time_frame>One year</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>MACE rate at 12 months</description>
  </secondary_outcome>
  <other_outcome>
    <measure>LV function</measure>
    <time_frame>90 days and one year</time_frame>
    <safety_issue>No</safety_issue>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">250</enrollment>
  <condition>Acute Myocardial Infarction</condition>
  <arm_group>
    <arm_group_label>SS-PCI</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Same sitting multivessel PCI as an adjunct to primary PCI</description>
  </arm_group>
  <arm_group>
    <arm_group_label>IRA-PCI</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>IRA only PCI with planned staging for non-IRA lesions</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>IRA-PCI</intervention_name>
    <description>IRA only PCI at the time of Primary PCI</description>
    <arm_group_label>IRA-PCI</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>SS-PCI</intervention_name>
    <description>Same sitting multivessel PCI as an adjunct to primary PCI</description>
    <arm_group_label>SS-PCI</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  High risk ST elevation myocardial infarction evidenced by: ≥2 mm ST elevation in 2
             anterior or lateral leads; or ≥2 mm ST elevation in 2 inferior coupled with ST
             depression in 2 contiguous anterior leads for a total ST deviation of ≥8 mm; or New
             left bundle branch block with at least 1 mm concordant ST elevation.

          -  Multivessel CAD as evidenced by ≥1 significant (≥70% by visual assessment or FFR&lt;0.80
             for 50-70% stenosis) stenosis in non-IRA.

          -  Successful IRA-PCI with &lt;10% residual angiographic stenosis and TIMI III flow.

          -  Written informed consent.

        Exclusion Criteria:

          -  Age ≤ 18 years.

          -  Prior coronary artery bypass graft (CABG) surgery.

          -  Administration of thrombolytic therapy.

          -  Non-IRA stenosis is a chronic total occlusion or located in left main artery.

          -  Hemodynamic instability evidenced by BP&lt;90 mmHg, Killip class ≥2, need for
             inotropes/vasopressors.

          -  Known renal insufficiency (estimated GFR &lt; 50ml/min).

          -  Contraindication to CMR.
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>St. Michael's hospital</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M5B 1W8</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Asim Cheema, MD</last_name>
      <phone>416-864-5739</phone>
      <email>cheemaA@smh.ca</email>
    </contact>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>May 2013</verification_date>
  <lastchanged_date>May 23, 2013</lastchanged_date>
  <firstreceived_date>March 23, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>St. Michael's Hospital, Toronto</investigator_affiliation>
    <investigator_full_name>Asim Nazir Cheema</investigator_full_name>
    <investigator_title>MD, PhD</investigator_title>
  </responsible_party>
  <keyword>Stent, Myocardial Infarction, Angioplasty, Coronary Intervention</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Infarction</mesh_term>
    <mesh_term>Myocardial Infarction</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
